Description
Trevogrumab research antibody
Trevogrumab is a fully human monoclonal antibody that binds and inhibits myostatin (GDF-8), a negative regulator of skeletal muscle mass.
Product details
| Compound | Trevogrumab (REGN1033) |
|---|---|
| Class | Anti-myostatin monoclonal antibody |
| Format | Lyophilised vial |
| Labelling | Compound name and strength on every container |
What research has examined
- Myostatin inhibition: ligand-neutralising antibody research.
- Muscle biology: muscle-mass endpoints in animal models.
- Clinical research: early-phase studies, including with activin A inhibition.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Independent literature: search PubMed for published studies.
Related research products
Lipo-B · GHK Basic · N-Acetyl Selank Nasal Spray · All peptides
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.